Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced an upcoming ...
MedPage Today on MSN
Endocrine Therapy Resistance in HR+/HER2- Breast Cancer: A Common Clinical Challenge
Endocrine therapy typically slows cell cycle progression by reducing cyclin D1, which partners with CDK4/6 to promote cell ...
Victoria's Secret known for its distinctive category of models, is switching things up this year by embracing inclusivity.
Brandon Dawson missed 1st place in 2024 by just six pounds. At the 2025 World Championship Pumpkin Weigh-Off, no one came ...
Encouraging preliminary activity observed across diverse set of advanced ALK-positive solid tumors Global enrollment ongoing for adult and adolescent ...
5don MSN
Dozens rescued as remnants of typhoon hits Alaska while nor’easter brings flooding to East Coast
Typhoon Halong brought hurricane-force winds in western Alaska while forecasters warn that major coastal flooding was likely ...
Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...
Discusses Business Transformation Strategy and Plans for Accelerated Growth October 16, 2025 5:00 PM EDTCompany ParticipantsXi-Yong Fu ...
In the histology-centric world of cancer medicine, further work is needed to increase genomic testing rates and educate ...
Child tax credit program boosted infant health…deadly breast cancer linked to living near Superfund sites…air pollution is ...
Basel, 13 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will present more than 30 abstracts ...
The Turning Point USA founder died after he was shot at an event on Sept. 10. Charlie Kirk was a husband and the father of two young kids at the time of his death at a campus university event in Utah.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results